Darifenacin

Darifenacin Struktur
133099-04-4
CAS-Nr.
133099-04-4
Englisch Name:
Darifenacin
Synonyma:
CS-773;UK88525;UK-88525;UK 88525;DARIFENACIN;Darifenacin, >=98%;Darifenacin USP/EP/BP;Tolafentrine Impurity 16;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe
CBNumber:
CB1506695
Summenformel:
C28H30N2O2
Molgewicht:
426.55
MOL-Datei:
133099-04-4.mol

Darifenacin Eigenschaften

alpha 
25D -20.6° (c = 1.0 in methylene chloride)
Siedepunkt:
614.3±55.0 °C(Predicted)
Dichte
1.192±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
Löslichkeit
Soluble in DMSO
Aggregatzustand
Powder
pka
pKa (25°): 9.2
Farbe
White to off-white

Sicherheit

Darifenacin Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Treatment for an overactive bladder.

Definition

ChEBI: 2-[(3S)-1-Ethylpyrrolidin-3-yl]-2,2-diphenylacetamide in which one of the hydrogens at the 2-position of the ethyl group is substituted by a 2,3-dihydro-1-benzofuran-5-yl group. It is a selective antagonist for the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions, and is used as the hydrobromide salt in the management of urinary incontinence.

Darifenacin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Darifenacin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 131)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
career henan chemical co
+86-0371-86658258 +8613203830695
sales@coreychem.com China 29812 58
Alchem Pharmtech,Inc.
8485655694
sales@alchempharmtech.com United States 63687 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427
sales@conier.com China 49979 58
TargetMol Chemicals Inc.
+1-781-999-5354; +17819995354
marketing@targetmol.com United States 32467 58
Qiuxian Baitai New Material Co., LTD
+8618330912755
sale2@hbyalin.com China 1658 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23541 58
Xi'an MC Biotech, Co., Ltd.
029-89275612 +8618991951683
mcbio_sales@163.com China 2251 58
Shaanxi Dideu Medichem Co. Ltd
+86-029-89586680 +86-18192503167
1026@dideu.com China 9996 58
Shijiazhuang Gantuo Biotechnology Co., Ltd
+8613373514458
gantuo02@cngantuo.com China 203 58
AFINE CHEMICALS LIMITED
+86-571-85134551
info@afinechem.com China 15083 58

133099-04-4()Verwandte Suche:


  • CS-773
  • 2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetaMide
  • UK 88525
  • UK88525
  • UK-88525
  • 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip
  • Darifenacin, >=98%
  • DARIFENACIN
  • 2-[1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide
  • (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-3-pyrrolidineacetamide
  • 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dipheny
  • 2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphe
  • 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-α,α-diphenyl-, (3S)-
  • Darifenacin USP/EP/BP
  • (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-α-α-diphenyl-3-pyrrolidineacetamide Hydrobromide
  • Tolafentrine Impurity 16
  • 133099-04-4
  • Pharmaceutical material and intermeidates
  • API
Copyright 2019 © ChemicalBook. All rights reserved